Last updated
QuidelOrtho: Ma Activity
QuidelOrtho plans to divest its testing unit for $1.5 billion
Source: Seeking Alpha — Market Currents
The leadership read
Consolidation of this kind shifts demand toward integration and transformation leadership bench strength in medtech.
Market context: The wider read — a Talent Market Index of 107.9 (Hot), up 2.4 month-on-month — shows Americas signal flow rising (+15.4pts).
QuidelOrtho: 1 signal in the last 90 days — in line with the MedTech median of 1 across 21 tracked companies; 0.1% of MitchelLake's Americas signal flow; 2 tracked across 95 days.
Also at QuidelOrtho →
More signals across MedTech
Ma Activity · Americas
Medtronic →Medtronic completed a $550M acquisition of Scientia Vascular, expanding its vascular intervention and treatment capabilities
Ma Activity · Americas
Analog Devices →In talks to acquire Empower Semiconductor for $1.5 billion, focusing on AI chip power management
Ma Activity · Americas
Boston Scientific →Boston Scientific invested $1.5bn to acquire a 34% equity stake in MiRus, an implants and procedural solutions developer
Ma Activity · Americas
McKesson →Apollo acquiring minority stake in McKesson's medical-surgical solutions business for $1.25bn, valuing the division at $13bn
Ma Activity · Americas
QuidelOrtho Corporation →QuidelOrtho Corporation completed acquisition of LEX Diagnostics, expanding into point-of-care molecular diagnostics with ultra-fast PCR platform delivering results in ~10 minutes
Ma Activity · Americas
Abbott →Abbott completed acquisition of Exact Sciences, establishing itself as a leader in the fast-growing oncology diagnostics market
Intelligence powered by Autonodal ↗